Attendees of the meeting will be immersed in educational content covering the latest clinical advances, basic science research, and innovative technologies relevant to advanced cardiothoracic disease.
“With over 1,400 scientific abstracts submitted, our scientific sessions represent the breadth and cutting-edge science of our field,” says Dr. Snyder. “We welcome you to join colleagues in Boston, either in person or virtually, to learn and share in our ISHLT community.” The scientific program is available to browse and review at the Annual Meeting website.
“On behalf of the ISHLT Board of Directors, we are looking forward to engaging with the worldwide ISHLT community at the upcoming Annual Meeting,” says ISHLT President Lara Danziger-Isakov, MD, MPH. “Whether you join the meeting in person or virtually, you’ll experience carefully curated cutting-edge science and education that will move our field forward. I’m particularly excited for the opportunity to create discussion and spark collaboration, especially since the ISHLT community has not met in person since 2019.”
For more information about ISHLT2022, and to register for the event, visit ishlt.org/ishlt2022.
The International Society for Heart and Lung Transplantation is a not-for-profit, multidisciplinary professional organization dedicated to improving the care of patients with advanced heart or lung disease through transplantation, mechanical circulatory support and innovative therapies. With members in more than 45 countries, ISHLT is the world’s largest organization dedicated to the research, education and advocacy of end-stage heart and lung disease. ISHLT members represent more than 15 different professional disciplines. For more information, visit www.ishlt.org.
SOURCE The International Society of Heart and Lung Transplantation